Radionetics
San Diego, US · Founded 2021 · 49 employees on LinkedIn · 3 known investors
Find your way into Radionetics
73 people in our graph share verified history with the Radionetics team — schools, employers, funds. One of them is your warm intro.
Jessica Mayerunlockedknows Brett Ewald · together at Villanova University (overlapped)
×2knows the team · via Radionetics
×7knows the team · via Villanova University
×2knows the team · via MD Anderson Cancer Center
Radionetics develops small molecule radiopharmaceuticals targeting GPCRs for cancer therapy and diagnosis, using a precision medicine approach that combines radioisotopes with potent, selective ligands. The company is headquartered in San Diego, California, and focuses on theranostic applications in oncology.
Founders & leadership
Radionetics was founded in 2021 by Brett Ewald.
BE
Brett EwaldinChief Operating Officer, Founding MemberBrett Ewald has 20 years of experience developing oncology drugs across pharma, biotech, and academic settings, with expertise in radiopharmaceuticals, small molecules, monoclonal antibodies, and immunotherapies. He is a founding member of Radionetics and served as COO and interim CEO, overseeing clinical development, business operations, and fundraising including a $140M strategic agreement with Eli Lilly.
AL
Alyssa LevininChief Financial Officer
Investors · 3
In the news
Frequently asked questions
- What does Radionetics do?
- Radionetics develops small molecule radiopharmaceuticals targeting GPCRs for cancer therapy and diagnosis, using a precision medicine approach that combines radioisotopes with potent, selective ligands. The company is headquartered in San Diego, California, and focuses on theranostic applications in oncology.
- Who founded Radionetics?
- Radionetics was founded by Brett Ewald in 2021.
- Who are Radionetics's investors?
- Radionetics's investors include 5AM Ventures, Frazier Life Sciences, DCVC Bio.
- Where is Radionetics headquartered?
- Radionetics is headquartered in San Diego, US.